Black Rock Inc. Spring Works Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,619,260 shares of SWTX stock, worth $207 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,619,260
Previous 5,438,857
3.32%
Holding current value
$207 Million
Previous $268 Million
20.93%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$247 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$141 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$129 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$126 Million5.82% of portfolio
-
State Street Corp Boston, MA3.09MShares$114 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.3B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...